Arrhythmia-induced cardiomyopathies: The riddle of the chicken and the egg still unanswered?

Europace

Volumn 14, Issue 4, 2012, Pages 466-473

  Simantirakis, Emmanuel N ^a   Koutalas, Emmanuel P ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Arrhythmia induced cardiomyopathies; Myocardial asynchrony; Reversible cardiomyopathies; Tachycardia induced cardiomyopathies

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS;

ARRHYTHMIA INDUCED CARDIOMYOPATHY; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CARDIOVERSION; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONVALESCENCE; DEFIBRILLATION; DISEASE COURSE; ECHOCARDIOGRAPHY; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART CONTRACTION; HEART PACING; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE REMODELING; HUMAN; NOMENCLATURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW;

ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; HUMANS; TERMINOLOGY AS TOPIC;

EID: 84859374549     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur348     Document Type: Review

References (80)

1. Gallagher JJ. Tachycardia and cardiomyopathy:the chicken-egg dilemma revisited. J Am Coll Cardiol 1985;6:1172-3. (Pubitemid 16219221)
2. Khasnis A, Jongnarangsin K, Abela G, Veerareddy S, Reddy V, Thakur R. Tachycardia-induced cardiomyopathy: a review of literature. Pacing Clin Electrophysiol 2005;28:710-21. (Pubitemid 41001445)
3. Chugh SS, Shen WK, Luria DM, Smith H. First evidence of premature ventricular complex-induced cardiomyopathy: a potentially reversible cause of heart failure. J Cardiovasc Electrophysiol 2000;11:328-9. (Pubitemid 30165353)
4. Tops LF, Schalij MJ, Bax JJ. The effects of right ventricular apical pacing on ventricular function and dyssynchrony: implications for therapy. J Am Coll Cardiol 2009;54:764-76.
5. Redfield MM, Kay GN, Jenkins LS, MIanulli M, Jensen DN, Ellenbogen KA. Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc 2000;75:790-5. (Pubitemid 30640636)
6. Fenelon G, Wijins W, Andries E, Brugada P. Tachycardiomyopathy: mechanisms and clinical implications. Pacing Clin Electrophysiol 1996;19:95-106. (Pubitemid 26033209)
7. Shinbane JD, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Sheinman MM. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 1997;29:709-15. (Pubitemid 27128241)
8. Gossage AM, Braxton Hicks JA. On auricular fibrillation. Q J Med 1913;6:435-40.
9. Fujino T, Yamashita T, Suzuki S, Sugiyama H, Sagara K, Sawada H et al. Characteristics of congestive heart failure accompanied by atrial fibrillation with special reference to tachycardia-induced cardiomyopathy. Circ J 2007;71:936-40. (Pubitemid 46833934)
10. Pizzale S, Lemery R, Green MS, Gollob MH, Tang AS, Birnie DH. Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter. Can J Cardiol 2009;25:469-72.
11. Furushima H, Chinushi M, Sugiura H, Aizawa Y. Radiofrequency catheter ablation for incessant atrioventricular nodal reentrant tachycardia normalized H-V block associated with tachycardia-induced cardiomyopathy. J Electrocardiol 2004;37: 315-9. (Pubitemid 39345941)
12. Medi C, Kalman JM, Haqqani H, Vohra JK, Morton JB, Sparks PB et al. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia. J Am Coll Cardiol 2009;53:1791-7.
13. Bensler JM, Frank CM, Rasavi M, Rasekh A, Saeed M, Haas PC et al. Tachycardiamediated cardiomyopathy and the permanent form of junctional reciprocating tachycardia. Texas Heart Inst J 2010;37:695-8.
14. Whipple GH, Sheffield LT, Woodman EG, Theophilis C, Friedman S. Reversible congestive heart failure due to chronic rapid stimulation of the normal heart. Proc N Engl Cardiovasc Soc 1962;20:39-40.
15. Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure. Treatment considerations of a dual epidemic. Circulation 2009;119:2516-25.
16. Edner M, Caidahl K, Bergfeldt L, Darpö B, Edvardsson N, Rosenqvist M. Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation. Br Heart J 1995;74:261-7.
17. Prinzen FW, Peschar M. Relation between the pacing inducedsequence of activation and left ventricular pump function in animals. Pacing Clin Electrophysiol 2002; 25:484-98. (Pubitemid 34438254)
18. Tops LF, Schalij MJ, Holman ER, van Erven L, van der Wall EE, Bax JJ. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. J Am Coll Cardiol 2006;48:1642-8. (Pubitemid 44529710)
19. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932-7. (Pubitemid 36736635)
20. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H et al. On behalf of the Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) trial. JAMA 2002;288:3115-23. (Pubitemid 36014128)
21. Duffee DF, Shen WK, Smith HC. Suppression of frequent prematureventricular contractions and improvement of left ventricular function in patients with presumed idiopathic dilated cardiomyopathy. Mayo Clin Proc 1998;73:430-3.
22. Baman TS, Lange DC, Ilg KJ, Gupta SK, Liu T, Alguire C et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm 2010;7:865-9.
23. Del Caprio Munoz F, Syed FF, Noheria A, Cha Y, Friedman PA, Hammill SC et al. Characteristics of premature ventricular complexes as correlates of reduced left ventricular systolic function: study of the burden, duration, coupling interval, morphology and site of origin of PVCs. J Cardiovasc Electrophysiol 2011;22:791-8.
24. Hasdemir C, Ulucan C, Yavuzgil O, Yuksel A, Kartal Y, Simsek E et al. Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias: the incidence, clinical and electrophysiological characteristics, and the predictors. J Cardiovasc Electrophysiol 2011;22:663-8.
25. Zupan I, Rakovec P, Budihna N, Brecelj A, Kozelj M. Tachycardia-induced cardiomyopathy in dogs; relation between chronic supraventricular and chronic ventricular tachycardias. Int J Cardiol 1996;56:75-81. (Pubitemid 26313314)
26. Thackray SD, Witte KK, Nikitin NP, Clark AL, Kaye GC, Cleland JG. The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population. Eur Heart J 2003;24:1143-52. (Pubitemid 36723580)
27. Tomita M, Spinale FG, Crawford FA, Zile MR. Changes in left ventricular volume, mass and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function. Circulation 1991;83:635-44.
28. Ohno M, Cheng CP, Little WC. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation 1994;89: 2241-50. (Pubitemid 24142804)
29. Byrne MJ, Raman JS, Alferness CA, Esler MD, Kaye DM, Power JM. An ovine model of tachycardia-induced degenerative dilated cardiomyopathy and heart failure with prolonged onset. J Card Fail 2002;8:108-15. (Pubitemid 34521421)
30. Massoure PL, Jais P, Sacher F, Haissaguerre M. Tachycardia-induced right ventricular cardiomyopathy: epicardial radiofrequency ablation of an unusual and unexpected ventricular tachycardia. J Cardiovasc Electrophysiol 2009;20:813-7.
31. Timek TA, Dagum P, Lai DT, Liang D, Daughters GT, Ingels NB et al. Pathogenesis of mitral regurgitation in tachycardia-induced cardiomyopathy. Circulation 2001; 104(Suppl I):I-47-53.
32. Spinale FG, Tanaka R, Crawford FA, Zile MR. Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy. Circulation 1992;85:717-29.
33. Moe GW, Stopps TP, Angus C, Forster C, DeBold AJ, Armstrong PW. Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure. J Am Coll Cardiol 1989;13: 173-9. (Pubitemid 19028695)
34. Zellner JL, Spinale FG, Eble DM, Hewett KW, Crawford FA Jr. Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure. Circ Res 1991;69:590-600.
35. Tanaka R, Fulbright BM, Mukherjee R, Burchell SA, Crawford FA, Zile MR et al. The cellular basis for the blunted response to beta-adrenergic stimulation in supraventricular tachycardia-induced cardiomyopathy. J Mol Cell Cardiol 1993;25: 1212-33.
36. Moe GW, Montgomery C, Howard RJ, Grima EA, Armstrong PW. Left ventricular myocardial blood flow, metabolism and effects of treatment with enalapril: further insights into the mechanisms of canine experimental pacing-induced heart failure. J Lab Clin Med 1993;131:294-301. (Pubitemid 23073136)
37. Spinale FG, Clayton C, Tanaka R, Fulbright BM, Mukherjee R, Schulte BA et al. Myocardial Na(+), K(+)-ATPase in tachycardia induced cardiomyopathy. J Mol Cell Cardiol 1992;24:277-94.
38. Coleman HN 3rd, Taylor RR, Pool PE, Whipple GH, Covell JW, Ross J Jr et al. Congestive heart failure due to chronic rapid stimulation of the normal heart. Am Heart J 1971;81:790-8.
39. O'Brien PJ, Ianuzzo CD, Moe GW, Stopps TP, Armstrong PW. Rapid ventricular pacing of dogs to heart failure: biochemical and physiological studies. Can J Physiol Pharmacol 1990;68:34-9. (Pubitemid 20107593)
40. Saavedra WF, Paolocci N, St John ME, Skaf MW, Stewart GC, Xie JS et al. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ Res 2002;90: 297-304. (Pubitemid 34633931)
41. Prinzen FW, Hunter WC, Wyman BT, McVeigh ER. Mapping ofregional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol 1999;33:1735-42.
42. Simantirakis EN, Prassopoulos VK, Chrysostomakis SI, Kochiadakis GE, Koukouraki SI, Lekakis JP et al. Effects of asynchronous ventricular activation on myocardial adrenergic innervations in patients with permanent dual-chamber pacemakers. Eur Heart J 2001;22:323-32.
43. Skalidis EI, Kochiadakis GE, Koukouraki SI, Chrysostomakis SI, Igoumenidis NI, Karkavitsas NS et al. Myocardial perfusion in patients with permanent ventricular pacing and normal coronary arteries. J Am Coll Cardiol 2001;37:124-9. (Pubitemid 32051727)
44. Olgun H, Yokokawa M, Baman T, Kim HM, Armstrong W, Good E et al. The role of interpolation in PVC-induced cardiomyopathy. Heart Rhythm 2011;8:1046-49.
45. Kanei Y, Friedman M, Ogawa N, Hanon S, Lam P, Schweitzer P. Frequent premature ventricular complexes originating from the right ventricular outflow tract are associated with left ventricular dysfunction. Ann Noninvasive Electrocardiol 2008;13: 81-5. (Pubitemid 351143707)
46. Clark DM, Plumb VJ, Kay GN. The hemodynamics of atrial fibrillation: the independent effect of an irregular RR interval. Circulation 1995;92(Suppl I):1-141.
47. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 1997;30:1039-45. (Pubitemid 27435898)
48. Schotten U, Greiser M, Benke D, Buerkel K, Ehrenteidt B, Stellbrink C et al. Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort. Cardiovasc Res 2002;53:192-201. (Pubitemid 34020780)
49. Hanna N, Cardin s, Leung TK, Nattel S. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovasc Res 2004;63:236-44. (Pubitemid 38900838)
50. Wilson RR, Douglas P, Hickey WF, Lanoce V, Ferrano N, Muhammad A et al. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation 1987;75:857-67. (Pubitemid 17052671)
51. Simantirakis EN, Kochiadakis GE, Vardakis KE, Igoumenidis NE, Chrysostomakis SI, Vardas PE. Left ventricular mechanics and myocardial blood flow following restoration of normal activation sequence in paced patients with long-term right ventricular apical stimulation. CHEST 2003;124:233-41. (Pubitemid 36851357)
52. Howard RJ, Stopps TP, Moe GW, Gotlieb A, Armstrong PW. Recovery from heart failure: structural and functional analysis in a canine model. Can J Physiol Pharmacol 1988;66:1505-12. (Pubitemid 19046761)
53. Jeong YH, Choi KJ, Song JM, Hwang ES, Park KM, Nam GB. Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy. Clin Cardiol 2008; 31:172-8.
54. Kay GN, Ellenbogen KA, Giudici M, Redfield MM, Jenkins LS, Mianulli M et al. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. J Interv Card Electrophysiol 1998;2:121-35. (Pubitemid 128513829)
55. Brignole M, Menozzi C, Gianfranchi L, Musso G, Mureddu R, Bottoni N et al. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation 1998;98:953-60. (Pubitemid 28446647)
56. Weerasooriya R, Davis M, Powell A, Szili-Torok T, Shah C, Whalley D et al. The Australian intervention randomized control of rate in atrial fibrillation trial (AIRCRAFT). J Am Coll Cardiol 2003;41:1697-1702. (Pubitemid 36584237)
57. Dandamudi G, Rampurwala AY, Mahenthiran J, Miller JM, Das MK. Pesistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction. Heart Rhythm 2008;5: 1111-4.
58. Lishmanov A, Chockalingam P, Senthilkumar A, Chockalingam A. Tachycardia-induced cardiomyopathy: evaluation and therapeutic options. Congest Heart Fail 2010;16:122-6.
59. Tops LF, Suffoletto MS, Bleeker GB, Boersma E, van der Wall EE, Gorcsan J III et al. Speckle-tracking radial strain reveals left ventricular dyssynchrony in patients with permanent right ventricular pacing. J Am Coll Cardiol 2007;50:1180-8. (Pubitemid 47375008)
60. Bogun F, Crawford T, Reich S, Koelling TM, Armstrong W, Good E et al. Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention. Heart Rhythm 2007;4:863-7. (Pubitemid 46959198)
61. Bhushan M, Asirvatham SJ. The conundrum of ventricular arrhythmia and cardiomyopathy: which abnormality came first? Curr Heart Fail Rep 2009;6:7-13.
62. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Europace 2010;12:1360-420.
63. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33. (Pubitemid 35417773)
64. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL et al. Rhythm control versus rate control for atrial fibrillationand heart failure. N Engl J Med 2008; 358:2667-77. (Pubitemid 351860859)
65. Ramesh Iyer V. Ventricular dysfunction: tachycardia induced cardiomyopathy. Indian Pacing Electrophysiol J 2008;8:202-10.
66. Nair GM, Nery PB, Diwakaramenon S, Healey JS, Connolly SJ, Morillo CA. A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2009;20:138-44.
67. Efremidis M, Sideris A, Xydonas S, Letsas KP, Alexanian IP, Manolatos D et al. Ablation of atrial fibrillation in patients with heart failure: reversal of atrial and ventricular remodeling. Hellenic J Cardiol 2007;48:19-25.
68. Gentlesk PJ, Sauer WH, Gerstenfeld EP, Lin D, Dixit S, Zado E et al. Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2007;18:9-14. (Pubitemid 44952735)
69. Lutomsky BA, Rostock T, Koops A, Steven D, Mullerleile K, Servatius H et al. Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. Europace 2008;10:593-9. (Pubitemid 351775299)
70. Victor F, Leclercq C, Mabo P, Pavin D, Deviller A, de Place C et al. Optimal right-ventricular pacing site in chronically implanted patients: a prospective randomized crossover comparison of apical and outflow tract pacing. J Am Coll Cardiol 1999; 33:311-6. (Pubitemid 29234190)
71. Bourke JP, Hawkins T, Keavey P, Tynan M, Jamieson S, Behulova R et al. Evolution of ventricular function during permanent pacing from either right ventricular apex or outflow tract following AV-junctional ablation for atrial fibrillation. Europace 2002;4:219-28. (Pubitemid 36104679)
72. Deshmukh PM, Romanyshyn M. Direct His-bundle pacing: present and future. Pacing Clin Electrophysiol 2004;27:862-70. (Pubitemid 38748153)
73. Yu CM, Chan JY, Zhang Q, Omar R, Yip GW, Hussin A et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Eng J Med 2009;361: 2123-34.
74. Kindermann M, Hennen B, Jung J, Geisel J, Bohm M, Frohlig G. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol 2006;47:1927-37.
75. Nazeri A, Massumi A, Rasekh A, Saeed M, Frank C, Razavi M. Cardiac resynchronization therapy in patients with right ventricular pacing-induced cardiomyopathy. Pacing Clin Electrophysiol 2010;33:37-40.
76. Leclercq C, Cazeau S, Lellouche D, Fossati F, Anselme F, Davy JM et al. Upgrading-from single chamber right ventricular to biventricular pacing in permanently paced patients with worsening heart failure: The RD-CHF Study. Pacing Clin Electrophysiol 2007;30:23-30.
77. Laurenzi F, Achilli A, Avella A, Peraldo C, Orazi S, Perego GB et al. Biventricular-upgrading in patients with conventional pacing system and congestive heartfailure: results and response predictors. Pacing Clin Electrophysiol 2007;30:1096-104. (Pubitemid 47300649)
78. Fujii B, Takami M. Normalization of left ventricular function following cardiac resynchronization therapy - left bundle branch block as a potential etiology of dilated cardiomyopathy. Circ J 2008;72:1030-3. (Pubitemid 351879931)
79. Nerheim P, Birger-Botkin S, Lubna Piracha DO, Olshansky B. Heart failure and sudden cardiac death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation 2004;110:247-52. (Pubitemid 38960795)
80. Huffman C, Wagman G, Fudim M, Zolty R, Vittorio T. Revesible cardiomyopathies - a review. Transplant Proc 2010;42:3673-8.